Last updated: 8 January 2019 at 3:14am EST

Neil Drake Net Worth




The estimated Net Worth of Neil Drake is at least $74.4 ezer dollars as of 15 March 2018. Neil Drake owns over 5,000 units of Obalon Therapeutics Inc stock worth over $74,375 and over the last 8 years Neil sold OBLN stock worth over $0.

Neil Drake OBLN stock SEC Form 4 insiders trading

Neil has made over 2 trades of the Obalon Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Neil bought 5,000 units of OBLN stock worth $19,800 on 15 March 2018.

The largest trade Neil's ever made was exercising 13,926 units of Obalon Therapeutics Inc stock on 2 February 2018 worth over $21,168. On average, Neil trades about 2,103 units every 5 days since 2017. As of 15 March 2018 Neil still owns at least 26,850 units of Obalon Therapeutics Inc stock.

You can see the complete history of Neil Drake stock trades at the bottom of the page.



What's Neil Drake's mailing address?

Neil's mailing address filed with the SEC is C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, STUIE F, CARLSBAD, CA, 92008.

Insiders trading at Obalon Therapeutics Inc

Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma... és David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.



What does Obalon Therapeutics Inc do?

Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.



Complete history of Neil Drake stock trades at Obalon Therapeutics Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Neil Drake
VP Research és Development
Megvenni $19,800
15 Mar 2018
Neil Drake
VP Research és Development
Opció Gyakorlat $21,168
2 Feb 2018


Obalon Therapeutics Inc executives and stock owners

Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: